CYCLANDELATE IN DIABETIC NEUROPATHY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSS-OVER STUDY

被引：0

作者：

HEIMANS, JJ ^{[1
]}

DRUKARCH, B ^{[1
]}

MATTHAEI, I ^{[1
]}

IJFF, GA ^{[1
]}

BERTELSMANN, FW ^{[1
]}

STRIJERS, RLM ^{[1
]}

NAUTA, J ^{[1
]}

机构：

[1] FREE UNIV AMSTERDAM HOSP,DEPT THEORY MED,1007 MB AMSTERDAM,NETHERLANDS

来源：

ACTA NEUROLOGICA SCANDINAVICA | 1991年 / 84卷 / 06期

关键词：

DIABETIC NEUROPATHY; THERAPY; CYCLANDELATE;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Cyclandelate has the ability to improve the rheological properties of the blood and therefore may improve blood supply of peripheral nerves. Previous studies in diabetic neuropathy have shown beneficial effects of the drug. We performed a double-blind, placebo-controlled, cross-over study in 40 diabetic patients with cyclandelate in a dose of 1600 mg daily. Motor and sensory nerve conduction velocities, late responses, thermal discrimination thresholds, vibration perception thresholds and pain scores were studied. We were not able to show any positive effect of the drug and therefore conclude that cyclandelate is not effective in the treatment of diabetic neuropathy.

引用

页码：483 / 486

页数：4

共 50 条

[41] Modulation of Hippocampal Hyperactivity in Schizophrenia With Levetiracetam: a Randomized, Double-Blind, Cross-Over, Placebo-Controlled Trial
Roeske, Maxwell
McHugo, Maureen
Rogers, Baxter
Avery, Suzanne
Armstrong, Kristan
Heckers, Stephan
NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 350 - 351
[42] Nicotine and behavioral markers of risk for schizophrenia:: A double-blind, placebo-controlled, cross-over study
Dépatie, L
O'Driscoll, GA
Holahan, ALV
Atkinson, V
Thavundayil, JX
Kin, NNY
Lal, S
NEUROPSYCHOPHARMACOLOGY, 2002, 27 (06) : 1056 - 1070
[43] DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY OF FLAVOXATE IN THE TREATMENT OF IDIOPATHIC DETRUSOR INSTABILITY
CHAPPLE, CR
PARKHOUSE, H
GARDENER, C
MILROY, EJG
BRITISH JOURNAL OF UROLOGY, 1990, 66 (05): : 491 - 494
[44] Nicotine and Behavioral Markers of Risk for Schizophrenia: A Double-Blind, Placebo-Controlled, Cross-Over Study
Lana Dépatie
Gillian A O′Driscoll
Anne-Lise V Holahan
Victoria Atkinson
Joseph X Thavundayil
N Ng Ying Kin
Samarthji Lal
Neuropsychopharmacology, 2002, 27 : 1056 - 1070
[45] The function of sildenafil on female sexual pathways: a double-blind, cross-over, placebo-controlled study
Caruso, S
Intelisano, G
Farina, M
Di Mari, L
Agnello, C
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2003, 110 (02) : 201 - 206
[46] Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy
Kessler, John A.
Smith, A. Gordon
Cha, Bong-Soo
Choi, Sung Hee
Wymer, James
Shaibani, Aziz
Ajroud-Driss, Senda
Vinik, Aaron
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2015, 2 (05): : 465 - 478
[47] 0.075% Capsaicin Lotion for the Treatment of Peripheral Neuropathy in ESRD Patients: A Multicenter Randomized Double-Blind Placebo-Controlled, Cross-Over Trial
Kittidanairuk, Parinada
Varothai, Narittaya
Nimkietkajorn, Veerapatr
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 5 - 5
[48] Efficacy and safety of mexiletine in non-dystrophic myotonias: a randomized, double-blind, placebo-controlled, cross-over study
Vicart, S.
Franques, J.
Bouhour, F.
Magot, A.
Pereon, Y.
Sacconi, S.
Nadaj-Pakleza, A.
Behin, A.
Zahr, N.
Hezode, M.
Fournier, E.
Payan, C.
Lacomblez, L.
Fontaine, B.
NEUROMUSCULAR DISORDERS, 2021, 31 : S118 - S118
[49] Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study
Andreas W. Schoenenberger
Renate Schoenenberger-Berzins
Christoph Auf der Maur
Paolo M. Suter
Athanasios Vergopoulos
Paul Erne
Clinical Research in Cardiology, 2012, 101 : 159 - 164
[50] Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study
Schoenenberger, Andreas W.
Schoenenberger-Berzins, Renate
Maur, Christoph Auf Der
Suter, Paolo M.
Vergopoulos, Athanasios
Erne, Paul
CLINICAL RESEARCH IN CARDIOLOGY, 2012, 101 (03) : 159 - 164

← 1 2 3 4 5 →